Aarti Drugs: Adhish Patil (promoter son) named MD; board changes
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 41st AGM on Sept 26, 2026, shareholders approved several board changes. WTD Uday Patil retired by rotation and was replaced by Nilesh Patil. Adhish P. Patil, son of CMD Prakash Patil and former CFO since 2014, appointed as Managing Director effective Oct 1, 2026, as part of an orderly leadership transition. Three Independent Directors re-appointed for second 5-year terms from March 29, 2027. Joint MD Harshit Savla and WTD Harit Shah also re-appointed for 5 years from June 1, 2027.
Promoter family succession with son as new MD; rest are routine re-appointments. Largely neutral for shareholders.